BridgeMD
New treatment option for Cervical Cancer
Official title Self-sampling for Non-attenders to Cervical Cancer Screening
ClinicalTrials.gov ID: NCT04226313
What this study is testing
- What it's testing
- The trial will evaluate whether self-sampling and human papillomavirus (HPV) testing may increase cervical cancer screening attendance among under-screened women in Czech Republic. Different ways of offering self-sampling device will be evaluated.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 65, women only. Healthy volunteers may be eligible.
You may be able to join if
- Women with age 30-65 years; for arm A women \> 65 years are allowed
- Women live in the Czech Republic.
- Women who have not participate in cervical cancer screening program in the Czech Republic for at least 3 years (Arm B and C).
- Women with completed informed consent.
- Women capable of self-sampling of cervicovaginal swab.
You likely can't join if
- Pregnant women.
- Women with no sexual intercourse experience.
- Women after hysterectomy including cervix.
The study team makes the final eligibility decision.
Where it's taking place
- Olomouc, Czechia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 30 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Olomouc, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.